发明名称 5-MEMBERED HETEROCYCLIC DERIVATIVE AND USE THEREOF FOR MEDICAL PURPOSES
摘要 <p>The present invention provides compounds useful as agents for the prevention or treatment of a disease associated with abnormal serum uric acid level which has a uricosuric activity or the like. The present invention relates to 5-membered heterocyclic derivatives represented by the following general formula (I) having xanthine oxidase inhibitory activities and useful as agents for the prevention or treatment of a disease associated with abnormality of serum uric acid level, prodrugs thereof, or salts thereof. In the formula (I), T represents nitro, cyano and the like; ring J represents aryl or heteroaryl; Q represents carboxy, 5-tetazolyl and the like; Y represents H, OH, NH 2 , halogen, haloalkyl and the like; X 1 and X 2 independently represent CR 2 or N; R 2 represents H, alkyl and the like; R 1 represents halogen, cyano, haloalkyl, A-D-E-G-L-M, -N(-D-L-M) 2 and the like, in the formula, A represents a single bond, O, S and the like; D, G and M independently represent optionally substituted alkylene, cycloalkylene, heterocycloalkylene, arylene, heteroarylene and the like; E and L independently represent a single bond, O, S, COO, SO 2 and the like.</p>
申请公布号 EP2133331(A4) 申请公布日期 2011.06.22
申请号 EP20080740194 申请日期 2008.04.10
申请人 KISSEI PHARMACEUTICAL CO., LTD. 发明人 SHIMIZU, KAZUO;TAKIGAWA, YASUSHI;FUJIKURA, HIDEKI;IIZUKA, MASATO;HIRATOCHI, MASAHIRO;KIKUCHI, NORIHIKO
分类号 C07D207/34;A61K31/402;A61K31/404;A61K31/415;A61K31/4155;A61K31/427;A61K31/4439;A61K31/454;A61K31/5377;A61K45/00;A61P13/02;A61P19/06;A61P43/00;C07D231/14;C07D231/16;C07D231/20;C07D231/38;C07D231/40;C07D401/04;C07D403/04 主分类号 C07D207/34
代理机构 代理人
主权项
地址